Download and read IASLC atlases, guides, periodicals and reports authored by leading experts in lung cancer.
Order
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) have updated and revised their 2013 evidence-based guideline: "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors." The "Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors" continues to set evidence-based standards for clinical molecular testing of non-small cell lung cancers (NSCLC) that effectively guides targeted therapy and treatment.
More Information
Published six times per year, the IASLC Lung Cancer News addresses the latest trends and news in the field.
More Information Download Latest Issue VISIT THE OFFICIAL SITE